Consistent with prior research, AFP was significantly elevated in HCC patients, whereas CA19-9 levels were higher in ICC patients.[21] However, relying solely on tumor markers offers limited sensitivity and specificity. The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.